Dose Escalation and Expansion (phase Ia/Ib) Study of GLS-010, a Recombinant Fully Human Antiprogrammed Death-1 Monoclonal Antibody for Advanced Solid Tumors or Lymphoma.
European journal of cancer(2021)
Key words
Programmed death-1 monoclonal antibody,Phase Ia/Ib study,Solid tumors,Safety,Efficacy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined